MAINZ BIOMED N.V. EO 1 financial statements, including revenue, expenses, profit, and loss

The total revenue of 4TO for the last quarter is 194.57 k EUR, and it's 13.22% higher compared to the previous quarter. The net income of Q4 23 is -4.70 M EUR.